Vaxart Inc (VXRT)
0.5993
-0.01
(-1.40%)
USD |
NASDAQ |
Nov 21, 16:00
0.5921
-0.01
(-1.20%)
After-Hours: 20:00
Vaxart Price to Book Value: 1.992 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 21, 2024 | 1.992 |
November 20, 2024 | 2.020 |
November 19, 2024 | 2.061 |
November 18, 2024 | 2.027 |
November 15, 2024 | 1.928 |
November 14, 2024 | 2.094 |
November 13, 2024 | 2.374 |
November 12, 2024 | 2.400 |
November 11, 2024 | 2.306 |
November 08, 2024 | 2.278 |
November 07, 2024 | 2.401 |
November 06, 2024 | 2.347 |
November 05, 2024 | 2.433 |
November 04, 2024 | 2.410 |
November 01, 2024 | 2.559 |
October 31, 2024 | 2.544 |
October 30, 2024 | 2.609 |
October 29, 2024 | 2.644 |
October 28, 2024 | 2.776 |
October 25, 2024 | 2.736 |
October 24, 2024 | 2.586 |
October 23, 2024 | 2.590 |
October 22, 2024 | 2.623 |
October 21, 2024 | 2.604 |
October 18, 2024 | 2.724 |
Date | Value |
---|---|
October 17, 2024 | 2.687 |
October 16, 2024 | 2.708 |
October 15, 2024 | 2.613 |
October 14, 2024 | 2.572 |
October 11, 2024 | 2.613 |
October 10, 2024 | 2.630 |
October 09, 2024 | 2.659 |
October 08, 2024 | 2.602 |
October 07, 2024 | 2.689 |
October 04, 2024 | 2.700 |
October 03, 2024 | 2.729 |
October 02, 2024 | 2.866 |
October 01, 2024 | 2.735 |
September 30, 2024 | 2.822 |
September 27, 2024 | 2.334 |
September 26, 2024 | 2.297 |
September 25, 2024 | 2.240 |
September 24, 2024 | 2.387 |
September 23, 2024 | 2.378 |
September 20, 2024 | 2.372 |
September 19, 2024 | 2.576 |
September 18, 2024 | 2.558 |
September 17, 2024 | 2.628 |
September 16, 2024 | 2.672 |
September 13, 2024 | 2.806 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6976
Minimum
Nov 22 2019
46.01
Maximum
Jul 14 2020
4.420
Average
3.168
Median
Price to Book Value Benchmarks
AIM ImmunoTech Inc | 4.631 |
Perspective Therapeutics Inc | 0.6173 |
Protalix BioTherapeutics Inc | 3.768 |
Electromed Inc | 5.722 |
Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 5.377 |
Price | 0.5993 |
Earnings Yield | -68.41% |
Market Cap | 136.33M |